LAPADULA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.050
AS - Asia 843
EU - Europa 643
SA - Sud America 123
AF - Africa 17
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.681
Nazione #
US - Stati Uniti d'America 2.019
CN - Cina 356
SG - Singapore 261
DE - Germania 147
UA - Ucraina 141
BR - Brasile 104
GB - Regno Unito 84
HK - Hong Kong 83
FI - Finlandia 76
FR - Francia 48
VN - Vietnam 46
IT - Italia 38
RU - Federazione Russa 29
IE - Irlanda 25
TR - Turchia 23
IN - India 21
CA - Canada 18
IR - Iran 10
PL - Polonia 10
AR - Argentina 8
MX - Messico 8
SE - Svezia 8
BD - Bangladesh 6
JP - Giappone 6
ZA - Sudafrica 6
MA - Marocco 5
NL - Olanda 5
AT - Austria 4
BE - Belgio 4
CH - Svizzera 4
ES - Italia 4
LT - Lituania 4
VE - Venezuela 4
AZ - Azerbaigian 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
HN - Honduras 2
IQ - Iraq 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
BH - Bahrain 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.681
Città #
Ashburn 221
Woodbridge 218
Fairfield 204
Singapore 138
Ann Arbor 131
Houston 117
Jacksonville 116
Chandler 102
San Jose 96
Hong Kong 83
Cambridge 77
Beijing 76
Seattle 74
Wilmington 71
The Dalles 52
Helsinki 51
Nanjing 49
Los Angeles 48
Princeton 42
New York 39
Lancaster 37
Munich 31
Dublin 25
Lauterbourg 22
Istanbul 21
Shanghai 18
Nanchang 17
Jinan 16
Shenyang 16
Ho Chi Minh City 15
Des Moines 14
Tianjin 14
Changsha 13
San Diego 12
Santa Clara 12
Moscow 11
San Francisco 11
Ardabil 10
São Paulo 10
Dallas 9
Hebei 9
Milan 9
Orem 9
Warsaw 9
Buffalo 8
Frankfurt am Main 8
Hanoi 8
London 8
Redondo Beach 8
Toronto 8
Phoenix 7
Council Bluffs 6
Dearborn 6
Kunming 6
Montreal 6
Stockholm 6
Turku 6
Washington 6
Hangzhou 5
Ningbo 5
Tokyo 5
Atlanta 4
Augusta 4
Brescia 4
Brussels 4
Chicago 4
Curitiba 4
Lanzhou 4
Lausanne 4
Monmouth Junction 4
Poplar 4
Porto Alegre 4
Rio de Janeiro 4
Baku 3
Biên Hòa 3
Bratislava 3
Brooklyn 3
City of London 3
Da Nang 3
Fuzhou 3
Guangzhou 3
Haikou 3
Johannesburg 3
Melegnano 3
Mexico City 3
Nuremberg 3
Paris 3
Querétaro 3
Taiyuan 3
Tashkent 3
Amsterdam 2
Belo Horizonte 2
Bishkek 2
Boston 2
Brasília 2
Campinas 2
Changchun 2
Charlotte 2
Chennai 2
Conselheiro Lafaiete 2
Totale 2.606
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 232
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 224
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 176
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 175
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. 172
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 172
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 166
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 165
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 162
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 162
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 160
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 157
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 153
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study 153
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 141
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 130
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 127
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals 127
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 126
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy. 119
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 113
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 112
Predictors of AIDS-defining events among advanced naïve patients after HAART. 103
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. 101
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 50
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 31
Totale 3.709
Categoria #
all - tutte 14.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 27 30 14
2021/2022221 34 21 5 10 0 12 7 16 5 30 22 59
2022/2023247 23 5 6 14 25 61 0 29 56 1 10 17
2023/2024245 11 7 25 32 12 48 13 6 55 13 4 19
2024/2025487 8 6 1 68 54 38 32 27 51 48 97 57
2025/2026919 93 93 43 117 158 78 158 45 59 75 0 0
Totale 3.709